KRAS and acute lymphoblastic leukemia: We then harnessed these metabolic insights for translational development, successfully demonstrating that targeting a polyamine biosynthesis enzyme with chemical inhibitors can severely restrict proliferation of KRAS-G12D B-ALL cells.